J Korean Pediatr Soc.
2003 Sep;46(9):939-943.
A Case of Recurrent Herpes Simplex Virus Disease of a Preterm Infant, Who Needed Continuous Oral Acyclovir Suppressive Therapy
- Affiliations
-
- 1Department of Pediatrics, Sung-Ae General Hospital, Seoul, Korea. nicu@chollian.net
- 2Department of Pediatrics, College of Medicine, Ulsan University Hospital, Ulsan, Korea.
- 3Department of Laboratory Medicine, Hangang Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea.
Abstract
- Neonatal herpes simplex virus(HSV) infections result in significant morbidity and mortality. Although acyclovir treatment has improved survival, severe neurological sequelae can occur in the majority of survivors. HSV infections limited to the skin, eyes and mouth(SEM) can cause neurologic impairment. A direct correlation exists between the development of neurologic deficits and the frequency of cutaneous HSV recurrences. National Institutes of Allergy and Infectious Diseases(NIAID) Collaborative Antiviral Study Group conducted a phase I/II trial of continuous oral acyclovir therapy for the suppression of cutaneous recurrences. We describe a preterm infant who had two recurrences after neonatal SEM disease had been treated with intravenous acyclovir, and there were no more recurrences after continuous oral acyclovir suppressive therapy for six months. We report this case with a review of related literature.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Acyclovir Resistance of Herpes Simplex Virus
- Relapsing Herpes Simplex Encephalitis Resulting in Kluver-Bucy Syndrome
- Drug Treatment of Herpes Simplex Infection
- Successful Treatment of Neonatal Herpes Simplex Infection Presenting as Fulminant Hepatitis with Acyclovir and Peritoneal Dialysis
- Relapsing Herpes Simplex Encephalitis
